Dai-ichi Life Holdings’s Xylem XYL Stock Holding History

Dai-ichi Life Holdings’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-4,061	Closed	-$213K	–	463
2016 Q3	$213K	Buy	+4,061	New	+$199K	0.01%	541
2015 Q3	–	Sell	-5,581	Closed	-$207K	–	632
2015 Q2	$207K	Hold	5,581	–	–	0.01%	567
2015 Q1	$195K	Hold	5,581	–	–	0.01%	600
2014 Q4	$212K	Hold	5,581	–	–	0.01%	576
2014 Q3	$198K	Hold	5,581	–	–	0.01%	604
2014 Q2	$218K	Hold	5,581	–	–	0.01%	588
2014 Q1	$203K	Hold	5,581	–	–	0.01%	587
2013 Q4	$193K	Hold	5,581	–	–	0.01%	603
2013 Q3	$156K	Hold	5,581	–	–	0.01%	654
2013 Q2	$150K	Buy	+5,581	New	+$154K	0.01%	617

Other funds holding XYL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dai-ichi Life Holdings's XYL Position: Q4 2016 in Review

Dai-ichi Life Holdings sold out of Xylem (XYL) in Q4 2016, closing a stake of 4,061 shares — an estimated $213K sold.

Dai-ichi Life Holdings first reported a position in XYL in Q2 2013 and held it in 10 quarters. The position peaked at $218K in Q2 2014. 559 funds tracked by Wall St. Rank hold XYL as of Q4 2016.

Dai-ichi Life Holdings reported no remaining Xylem position as of Q4 2016 after selling out during the quarter.
Dai-ichi Life Holdings sold 4,061 Xylem shares in Q4 2016, an estimated $213K.
Dai-ichi Life Holdings first reported a position in Xylem in Q2 2013 and held it in 10 quarters.
Dai-ichi Life Holdings's Xylem position peaked at $218K in Q2 2014.
559 funds tracked by Wall St. Rank held Xylem as of Q4 2016.

Based on Dai-ichi Life Holdings's 13F filing for Q4 2016, filed 14 Feb 2017.